Conferences

Quickly consult our archives filtering by year :

 „Capture Deal Value – When and How?“

The 2019 Swiss Healthcare Licensing Group (HLG) Winter Conference focused on the topic “Capture Deal Value – When and How?”

The pharmaceutical industry is facing increasing challenges to cope with the quickly changing world economy. The requirements in healthcare are becoming ever more demanding considering the higher standard of data, financial investments and time, let alone governments` cost-containment measures getting more restrictive.

Both new and innovative molecules in the pipeline and growing access of patients to drug treatment especially in emerging markets are at the same time positive signals though. It seems that the pharmaceutical industry still finds room for creative ways to explore and implement new business models keeping pace with current changes in the healthcare environment.

Over three days, nearly 100 delegates from Switzerland, Europe, the US and Asia gathered in the Gruyère region to explore current and future innovative ways when and how to capture maximum deal value.

Conference Director, Ragip Ziyal with the active support of the entire Swiss HLG Board, gathered a global forum of high caliber speakers not only from the healthcare and consumer industry but also governmental initiatives to capture the maximum value for assets in the best manner and at the right time by (I) learning how synergies may be exploited for example during M&A transactions, (II) discussing the need for strategic access to new technologies and (III) looking at new players such as new public and public-private funding schemes as well as patient and non-profit organizations to support R&D funding.Read More…

LAST CHANCE TO REGISTER and secure a conference space! 

Book your hotel here!

There are several options available for hotel bookings within different price categories, but all are limited.

 

 

“CAPTURE DEAL VALUE– WHEN AND HOW?”

We are all interested in making deals and see more of these in the media; this is at least the „bread and butter“ for BD&L professionals and what they are measured against.

Main questions in this context are not only to explore creative deal structures on how to maximise the value of any asset. We are all focusing on and thus serving the shareholders

to achieve their goals but also when the right time is to harvest the asset value they invested in for many years.

During the Conference, we will shed light on how to capture the maximum value for a deal

in the best manner and at the right time. The conference shall have three streams:

• Learning how synergies may be exploited for example during M&A transactions.

• Discussing the need for strategic access to new technologies.

• Looking at new players such as new public and public-private funding schemes as well

as patient and non-profit to support R&D funding.

Join us on Sunday afternoon to be part of our exciting 2019 Winter Conference with high-caliber speakers covering interesting topics.

Explore our inspiring program which will be available on our conference website www.swisshlg-conference.com It will be updated regularly over the next few weeks with newly confirmed speakers their abstracts and bios.

Register now and secure a conference space as well as hotel booking. There are several options available for hotel bookings within different price categories, but all are limited.

We are looking forward to welcoming you at the 2019 Swiss HLG Winter Conference in the fascinating scenery of the Gruyère region. Let’s learn together how to best capture deal

values!

Swiss_HLG_Winter_Conference_2019_flyer

This is a great new opportunity to attend an event for business development executives from Swiss and European pharma and biotech companies seeking to work with partners from China to expand into the Chinese market.

The European-Chinese Pharma Partnering Event 2018 offers insights into the rapidly evolving Chinese pharma and biotech industry, its established as well as emerging players and their strategy to expand their capabilities and portfolios. Join us for an exclusive opportunity to meet Chinese executives looking to partner with Western pharma and biotech companies. The focus of this dedicated partnering event is to help life sciences companies find strategic partners, market expansion and/or funding in China. The two-day program consists of two parts: the main conference with industry speakers and company presentations, and separate partnering meetings (by invitation only).
The European-Chinese Pharma Partnering Event 2018 may be just the beginning of your relationship with the surging Chinese pharma industry.

Friday, October 12th, 2018: Switzerland Innovation Park Basel Area, Gewerbestrasse 24, 4123 Allschwil, Switzerland

Register HERE! (limited to 60 seats)

European-Chinese Pharma Partnering 2018

 

Organized by the Swiss Biotech Association & supported by the Swiss Healthcare Licensing

The Swiss Biotech Day is the leading biotechnology conference in Switzerland, with two editions, one in spring and one in fall. Join Swiss Biotech Day Fall, coinciding with Europa BIO’s European Biotech Week, to meet senior executives from the Swiss biotech industry – entrepreneurs, investors, researchers, analysts, political decision-makers Group and stakeholders.
This year’s half-day program focuses on lessons to be learned from the race to innovate, with perspectives from drug developers, investors and academia. Networking opportunities accompany plenary sessions.

Speakers Sessions

The conference takes place at the Aquatis Hotel, September 27th, 2018, 1 pm to 6 pm. 

The registration fee for Swiss HLG members is only 50 CHF 

>>Click here to register

                                                                                  

Join us, become a member !

Join Swiss HLG
as a member

Newsletter

Keep up to date with the latest information by signing up to our newsletter

Why it's worth joining us !

Learn more about Swiss HLG
and our initiatives